ALLR logo
ALLR NASDAQ US

Allarity Therapeutics, Inc. - Common stock

Healthcare · Biotechnology Website · IPO Dec 2021
$1.16
▲ +$0.03 (+2.65%)
Vol 55K
4
Quality Score
fail
Mkt Cap
$17.3M
ROE
-112.1%
D/E
11.57
Beta
0.26
52W
$1–$2

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

TPST
Tempest Therapeutics Inc
$14.1M
JSPR
Jasper Therapeutics Inc
$51.2M
OTLK
Outlook Therapeutics Inc
$101.3M
LTRN
Lantern Pharma Inc
$33.9M
TVGN
Tevogen Bio Holdings Inc
$65.8M
KTTA
Pasithea Therapeutics Corp
$29.8M
BIAF
bioAffinity Technologies Inc
$5.3M

Earnings

Beat rate: 100.0%
Next Report May 09, 2026
EPS Estimate: $-0.24
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.24 — —
Sep 2025 $-0.23 $-0.19 +$0.04
Jun 2025 $-0.21 $-0.15 +$0.06
Sep 2024 $-8.69 $-7.71 +$0.98

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -173.3% -173.3% -173.3% -173.3% -173.3% -112.1%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 11.30 11.30 11.30 11.30 11.30 11.57
Current Ratio 2.31 2.31 2.31 2.31 2.31 2.33

Key Ratios

ROA (TTM)
-64.9%
P/B
0.4
EPS (TTM)
$-2.31
CF/Share
$-30.29
52W High
$2.35
52W Low
$0.61
$0.61 52-Week Range $2.35

How does ALLR compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

ALLR AAPG ABEO ABOS ABP

ALLR valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.4
▼ 82% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

ALLR profitability vs Biotechnology peers

ROE
-112.1%
▼ 66% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-64.9%
▼ 39% below peers (-46.7%)
vs Peers
vs Industry
Weak

ALLR financial health vs Biotechnology peers

D/E ratio
11.6
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
2.3
▼ 48% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼ 73% below peers (1.0)
vs Peers
vs Industry
More volatile

ALLR fundamentals radar

ALLR Peer median Industry

ALLR profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ALLR vs peers: key metrics

Latest News

No related news yet